title: Quantitative trait locus analysis, pathway analysis, and consomic mapping show genetic variants of Tnni3k, Fpgt, or H28 control susceptibility to viral myocarditis.
abstract: Coxsackievirus B3 (CVB3) infection is the most common cause of viral myocarditis. The pathogenesis of viral myocarditis is strongly controlled by host genetic factors. Although certain indispensable components of immunity have been identified, the genes and pathways underlying natural variation between individuals remain unclear. Previously, we isolated the viral myocarditis susceptibility 1 (Vms1) locus on chromosome 3, which influences pathogenesis. We hypothesized that confirmation and further study of Vms1 controlling CVB3-mediated pathology, combined with pathway analysis and consomic mapping approaches, would elucidate both pathological and protective mechanisms accounting for natural variation in response to CVB3 infection. Vms1 was originally mapped to chromosome 3 using a segregating cross between susceptible A/J and resistant B10.A mice. To validate Vms1, C57BL/6J-Chr 3(A)/NaJ (a chromosome substitution strain that carries a diploid A/J chromosome 3) were used to replicate susceptibility compared with resistant C57BL/6J (B6). A second segregating F2 cross was generated between these, confirming both the localization and effects of Vms1. Microarray analysis of the four strains (A/J, B10.A, C57BL/6J, and C57BL/6J-Chr 3(A)/NaJ) illuminated a core program of response to CVB3 in all strains that is comprised mainly of IFN-stimulated genes. Microarray analysis also revealed strain-specific differential expression programs and genes that may be prognostic or diagnostic of susceptibility to CVB3 infection. A combination of analyses revealed very strong evidence for the existence and location of Vms1. Differentially expressed pathways were identified by microarray, and candidate gene analysis revealed Fpgt, H28, and Tnni3k as likely candidates for Vms1.
authors.affiliation: Department of Human Genetics, McGill University, Montreal, Quebec H3A 1B1, Canada.
authors.forename: Sean A
authors.initials: SA
authors.lastname: Wiltshire
authors.forename: Gabriel André
authors.initials: GA
authors.lastname: Leiva-Torres
authors.forename: Silvia M
authors.initials: SM
authors.lastname: Vidal
mesh_terms: D000818:Animals; D002874:Chromosome Mapping / Q000379:methods; D003384:Coxsackievirus Infections / Q000235:genetics* / Q000276:immunology; D029822:Enterovirus B, Human / Q000276:immunology / Q000502:physiology; D005260:Female; D020869:Gene Expression Profiling; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D014644:Genetic Variation; D054884:Host-Pathogen Interactions / Q000235:genetics / Q000276:immunology; D008297:Male; D051379:Mice; D008805:Mice, Inbred A; D008810:Mice, Inbred C57BL; D015778:Minor Histocompatibility Antigens / Q000235:genetics; D009205:Myocarditis / Q000235:genetics* / Q000276:immunology; D009206:Myocardium / Q000378:metabolism / Q000473:pathology; D009713:Nucleotidyltransferases / Q000235:genetics; D020411:Oligonucleotide Array Sequence Analysis; D011494:Protein Kinases / Q000235:genetics; D017346:Protein Serine-Threonine Kinases; D040641:Quantitative Trait Loci / Q000235:genetics*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction / Q000235:genetics; D013997:Time Factors
chemical_list: C414365:H28 antigen; D015778:Minor Histocompatibility Antigens; D011494:Protein Kinases; C545832:Tnni3k protein, mouse; D017346:Protein Serine-Threonine Kinases; D009713:Nucleotidyltransferases; C560121:fucose-1-phosphate guanylyltransferase, mouse